Product Images Pregabalin

This is a description of Pregabalin Capsules 150mg, a generic medication for Lyrica. Each capsule contains 150mg of pregabalin and is manufactured by Ascend Laboratories, LLC. The medication is available in a preferred pharmaceutical packaging with an expiration date, lot and batch number, and a product number. The label contains directions in English and warns about the transfer of the drug to others. The text also contains a billing chart log and an insurance NDC.*

This text appears to be a medical formula for calculating CLCr (Creatinine Clearance) based on age, weight, and serum creatinine level of a patient. The formula is gender-specific, with a minimum value of 0.85 required for female patients. However, the text appears to be incomplete and it is not possible to interpret it fully.*

This appears to be a table showing results from two studies (E1 and E3) that tested various dosages of a medication vs a placebo. The table includes the percentage change in some outcome measure (labeled "Faon") for each treatment group compared to the placebo group. One treatment group had a significant difference from the placebo group. However, without more context it is not possible to determine what the outcome measure or medication was.*

Percentage improvement in pain from baseline can be measured using Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, or placebo. However, the first line "Roant of Patients Improved" appears to be a typographical error as it does not make sense.*

This looks like a table displaying different daily doses of Pregabalin and their corresponding percentages of improvement in pain from baseline. However, without the proper context, it is difficult to draw any further conclusions.*